end-stage disease 中文意思是什麼
end-stage disease
解釋
晚期-
In the vast majority of cases, patients with hepatic hydrothorax have end - stage liver disease
在絕大多數情況下,終末期肝病病人有肝性胸水。 -
Kidney disease can lead to kidney failure or end - stage renal disease
腎臟疾病能導致腎功能衰竭(終末期腎疾病) 。 -
Amount and activity of dendritic cells in peripheral blood of patients with end - stage renal disease
終末期腎臟病患者外周血樹突細胞的數量及活性 -
Continuous ambulatory peritoneal dialysis ( capd ) is a well - established treatment modality for end - stage renal disease
摘要以連續性可動式腹膜透析術治療連毒癥病人愈來愈普遍, ?這些病人常有腹壁疝氣。 -
The study chooses end - stage renal disease patient samples less than 55 years old who had dialysis cure within two years
摘要本研究關心嚴重生理功能損傷之失能性疾病(如失去重要器官或肢體殘障)患者,在失能初期驟然面對殘障的心理調適歷程。 -
These statistics raise the daunting prospect of an epidemic of diabetic nephropathy in a deeloping world unable to cope with its repercussions ? a world where end - stage renal disease is a death sentence
在發展中國家的晚期腎病患者,無異于被叛了死刑,所以,糖尿病腎病將在發展中國家流行的趨勢令人擔心。 -
According to a surey published in 2003, 5 diabetic nephropathy was the most common cause of end - stage renal disease in 9 of 10 asian countries, with an incidence that had increased from 1. 2 % of the oerall population with end - stage renal disease in 1998 to 14. 1 % in 2000
2003年公布的一項調查結果表明,在大部分( 9 / 10 )的亞洲國家裡,糖尿病腎病是引起腎終末期疾病的最常見原因,由糖尿病腎病引起的腎終末期疾病的發病率已經從1998年占總腎終末期疾病患者數的1 . 2 %增加到2000年的14 . 1 % 。 -
Model for end - stage liver disease, me
評分及晚近終末期肝病的危險度評分模型 -
Model for end - stage liver disease me
終末期肝病模型評分與肝移植 -
Patients were followed for clinical toxicities, alterations in model for end - stage - liver disease ( meld ) score, tumor response, downstaging to rfa, resection, transplantation, and survival
隨訪觀察患者的臨床毒性,晚期肝臟疾病模型( meld )評分變化,腫瘤反應,爭取降期可射頻消融( rfa ) ,切除,肝移植和存活率。 -
The recent years saw successful investigation into the novel use of autologous bone marrow transplant for enhancement of neovascularisation in patients with " end - stage " ischaemic heart disease, which is a potentially safer, cheaper and more effective method for therapeutic angiogenesis than using angiogenic growth factors
近年來,醫學院就自體骨髓移植這項嶄新技術取得了重大的進展,更能提升末期?血心臟病患者的血管新生。相對于傳統利用血管生長因子,這項用於治療性血管新生的技術,可說是更有效、更安全且更便宜。 -
We are also developing the heart transplantation program for patients with end - stage heart failure and heart - lung transplantation program for patients with severe pulmonary vascular disease due to congenital heart disease
除了一般的心臟血管手術外,本院亦在發展心臟移植及心肺移植手術,以期對于末期的心臟病人如擴張性心肌癥,先天性心臟病人並發極度肺動脈高血壓等的治療能有所幫助。 -
Since lung transplantation ( ltx ) was first performed in 1983, it has been a viable therapy for patients with progressive end - stage lung disease
從1983年第一例肺移植以來,它成為進展終末期肺病比國內人可選擇治療。 -
Methods : australian and new zealand patients who received low - dose hbig plus lamivudine following liver transplantation for hbv - related end - stage liver disease were studied
方法:選擇澳洲和紐西蘭曾接受乙型肝炎免疫球蛋白聯合拉米夫定的患者,對這類患者行肝移植后發生的與乙型肝炎病毒相關的末期肝臟疾病進行研究。 -
Lung transplants are a common therapy for many end - stage lung diseases such as chronic obstructive pulmonary disease, cystic fibrosis, pulmonary hypertension, idiopathic pulmonary fibrosis and other diseases
肺移植是許多終末期肺病的普遍治療方法,例如慢性阻塞性肺病、囊性纖維病、肺動脈高血壓、特發性肺纖維化等疾病。
分享友人